These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3735498)

  • 1. Prognostic factors in metastatic renal carcinoma.
    Maldazys JD; deKernion JB
    J Urol; 1986 Aug; 136(2):376-9. PubMed ID: 3735498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.
    Naito S; Kimiya K; Sakamoto N; Soejima T; Ueda T; Kumazawa J; Osada Y; Kurozumi T; Sagiyama K; Ariyoshi A
    Urology; 1991 Feb; 37(2):95-9. PubMed ID: 1992596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma.
    Althausen P; Althausen A; Jennings LC; Mankin HJ
    Cancer; 1997 Sep; 80(6):1103-9. PubMed ID: 9305711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    Int Urol Nephrol; 1998; 30(6):681-7. PubMed ID: 10195860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival.
    Neves RJ; Zincke H; Taylor WF
    J Urol; 1988 Jun; 139(6):1173-6. PubMed ID: 3373580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
    Han KR; Pantuck AJ; Bui MH; Shvarts O; Freitas DG; Zisman A; Leibovich BC; Dorey FJ; Gitlitz BJ; Figlin RA; Belldegrun AS
    Urology; 2003 Feb; 61(2):314-9. PubMed ID: 12597937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.
    Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE
    Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of osseous metastases in patients with renal cell carcinoma.
    Jung ST; Ghert MA; Harrelson JM; Scully SP
    Clin Orthop Relat Res; 2003 Apr; (409):223-31. PubMed ID: 12671506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of metastatic renal cell carcinoma.
    Tobisu K; Kakizoe T; Takai K; Tanaka Y; Mizutani T
    Jpn J Clin Oncol; 1990 Sep; 20(3):263-7. PubMed ID: 2255101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of renal cell carcinoma metastases: prognostic significance.
    Takashi M; Takagi Y; Sakata T; Shimoji T; Miyake K
    Int Urol Nephrol; 1995; 27(1):1-8. PubMed ID: 7615361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of surgical treatment of renal cell carcinoma with solitary metastasis.
    Dineen MK; Pastore RD; Emrich LJ; Huben RP
    J Urol; 1988 Aug; 140(2):277-9. PubMed ID: 3398121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary metastases from renal cell carcinoma: a review.
    Tongaonkar HB; Kulkarni JN; Kamat MR
    J Surg Oncol; 1992 Jan; 49(1):45-8. PubMed ID: 1548881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
    Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
    J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment and prognosis of T 4 renal cell carcinoma].
    Fukuda M; Satomi Y; Nakahashi M; Senga Y; Oogo Y; Udagawa K; Asakura T
    Nihon Hinyokika Gakkai Zasshi; 1999 Sep; 90(9):753-62. PubMed ID: 10517083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.
    Bex A; Haanen JB; Vyth-Dreese FA; Horenblas S; de Gast GC
    Urol Int; 2008; 80(4):367-71. PubMed ID: 18587246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage IV renal cell carcinoma.
    Frank W; Stuhldreher D; Saffrin R; Shott S; Guinan P
    J Urol; 1994 Dec; 152(6 Pt 1):1998-9. PubMed ID: 7966660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.